0
0
According to a study, the Biontech/Pfizer vaccination reduces the risk of infection with the delta variant of the coronavirus in adolescents by 90 percent.
It also provided 93 percent protection against contracting symptoms of that variant of the virus, a spokeswoman for Israel’s Clalit health insurance company confirmed Wednesday.
Together with researchers from Harvard University (USA), data from 94,354 twice-vaccinated adolescents between the ages of 12 and 18 were evaluated, a statement said. These were compared with data from a corresponding number of unvaccinated adolescents. The findings have been published in the New England Journal of Medicine.
One billion Corona vaccinations in the European Region.
The data were collected between June 8 and Sept. 14 of this year, the scientists reported. That is, during the fourth Corona wave in Israel, when the delta variant dominated the infection event. The scientists were unable to say how the vaccination affected the risk of becoming seriously ill, having to be hospitalized or dying. Such cases are too rare in young people, they said.
In Israel, the Biontech/Pfizer preparation is almost exclusively injected. The country began vaccinating children as young as 12 in early June. According to the Ministry of Health, around 61 percent of the country’s 9.4 million inhabitants have been vaccinated twice – 45 percent of 12- to 15-year-olds and 75 percent of 16- to 19-year-olds.
- source: k.at/picture:pixabay.com
This post has already been read 705 times!
